article Open AccessTop 1% cited
Antibody responses to SARS-CoV-2 in patients with COVID-19
Nature Medicine · 2020 · Vol. 26(6) · pp. 845–848
Quanxin Long✉(Chongqing Medical University)Bai-Zhong Liu(Chongqing Medical University)Haijun Deng(Chongqing Medical University)Gui-Cheng Wu(Chongqing University)Kun Deng(Chongqing Medical University)Yao-Kai Chen(Chongqing Public Health Medical Center)Pu Liao(First People's Hospital of Chongqing)Jingfu Qiu(Chongqing Public Health Medical Center)Yong Lin(Chongqing Medical University)Xue-Fei Cai(Chongqing Medical University)De-Qiang Wang(Chongqing Medical University)Yuan Hu(Chongqing Medical University)Ji-Hua Ren(Chongqing Medical University)Ni Tang(Chongqing Medical University)Yinyin Xu(Chongqing Medical University)Li-Hua Yu(Chongqing Medical University)Zhan Mo(Chongqing Medical University)Fang Gong(Chongqing Medical University)Xiaoli Zhang(Chongqing University)Wen-Guang Tian(Chongqing Medical University)Hu Li(Chongqing University)Xian-Xiang Zhang(Chongqing University)Jiang-Lin Xiang(Chongqing University)Hong-Xin Du(Chongqing University)Hua-Wen Liu(Chongqing University)Chunhui Lang(Chongqing University)Xiao-He Luo(Chongqing University)Shao-Bo Wu(Chongqing University)Xiao-Ping Cui(Chongqing University)Zheng Zhou(Chongqing University)Manman Zhu(Chongqing Medical University)Jing Wang(Chongqing Public Health Medical Center)Cheng-Jun Xue(Chongqing Public Health Medical Center)Xiao-Feng Li(Chongqing Public Health Medical Center)Li Wang(Chongqing Public Health Medical Center)Zhi-Jie Li(First People's Hospital of Chongqing)Kun Wang(First People's Hospital of Chongqing)Chang-Chun Niu(First People's Hospital of Chongqing)Qing-Jun Yang(First People's Hospital of Chongqing)Xiao-Jun Tang(Chongqing Public Health Medical Center)Yong Zhang(Chongqing Public Health Medical Center)Xia-Mao Liu(Dalian Medical University)Jin-Jing Li(Dalian Medical University)De-Chun ZhangFan ZhangPing LiuJun Yuan(Chongqing Medical University)Qin LiJieli Hu(Chongqing Medical University)Juan Chen(Chongqing Medical University)Ailong Huang(Chongqing Medical University)
SARS-CoV-2 and COVID-19 ResearchCOVID-19 Clinical Research StudiesSARS-CoV-2 detection and testingSeroconversionSerologyMedicineAsymptomaticSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Coronavirus disease 2019 (COVID-19)AntibodyImmunologyTiterVirology
MeSH terms
BetacoronavirusCOVID-19SARS-CoV-2AdultAgedAntibodies, ViralAntibody FormationAntiviral AgentsFemaleHumansImmunoglobulin GImmunoglobulin MMaleMiddle AgedPneumonia, Viral
Funding
- National Natural Science Foundation of China
Citations
3,104
FWCI
73.66
field-weighted impact
References
8
Percentile
100%
vs. same field & year
Citations per year
Cited by
Early induction of functional SARS-CoV-2-specific T cells associates with rapid viral clearance and mild disease in COVID-19 patients
Cell Reports · 2021 · 792 citations
Clinical and immunological assessment of asymptomatic SARS-CoV-2 infections
Nature Medicine · 2020 · 3,049 citations
IgA dominates the early neutralizing antibody response to SARS-CoV-2
Science Translational Medicine · 2020 · 1,115 citations
Immune response to SARS‐CoV‐2 and mechanisms of immunopathological changes in COVID‐19
Allergy · 2020 · 1,184 citations
References
Laboratory Diagnosis of COVID-19: Current Issues and Challenges
Journal of Clinical Microbiology · 2020 · 1,327 citations
Citation Network
How this paper connects to the literature. Drag to explore, click any node to open that paper.